place

Wellcome Centre for Human Genetics

1994 establishments in EnglandBiotechnology in the United KingdomDepartments of the University of OxfordEducational institutions established in 1994Genetics in the United Kingdom
Genetics or genomics research institutionsHuman geneticsMedical research institutes in the United KingdomResearch institutes in OxfordWellcome Trust
Henry Wellcome Building for Genomic Medicine
Henry Wellcome Building for Genomic Medicine

The Wellcome Centre for Human Genetics is a human genetics research centre of the Nuffield Department of Medicine in the Medical Sciences Division, University of Oxford, funded by the Wellcome Trust among others.

Excerpt from the Wikipedia article Wellcome Centre for Human Genetics (License: CC BY-SA 3.0, Authors, Images).

Wellcome Centre for Human Genetics
Roosevelt Drive, Oxford Headington

Geographical coordinates (GPS) Address Nearby Places
placeShow on map

Wikipedia: Wellcome Centre for Human GeneticsContinue reading on Wikipedia

Geographical coordinates (GPS)

Latitude Longitude
N 51.752248 ° E -1.215255 °
placeShow on map

Address

Old Road Campus, University of Oxford

Roosevelt Drive
OX3 7DQ Oxford, Headington
England, United Kingdom
mapOpen on Google Maps

Henry Wellcome Building for Genomic Medicine
Henry Wellcome Building for Genomic Medicine
Share experience

Nearby Places

Richard Doll Building
Richard Doll Building

The Richard Doll Building (RDB) is a University of Oxford building on the Old Road Campus, in Headington, east Oxford, England. The building is named after the physician and epidemiologist Sir Richard Doll CH OBE FRS (1912–2005).The building houses the Nuffield Department of Population Health and includes the National Perinatal Epidemiology Unit, Clinical Trial Service Unit, Epidemiological Studies Unit, Cancer Epidemiology Unit, Screening Unit, and the Office of the Regius Professor of Medicine.The Richard Doll Building was designed by Nicholas Hare Architects in 2006. The building is 9,000m2 and won the RIBA South-East Award in 2007.A plaque inside the building contains the following quotation by Richard Doll: Death in old age is inevitable, but death before old age is not. In previous centuries 70 years used to be regarded as humanity's allotted span of life, and only about one in five lived to such an age. Nowadays, however, for non-smokers in Western countries, the situation is reversed: only about one in five will die before 70, and the non-smoker death rates are still decreasing, offering the promise, at least in developed countries, of a world where death before 70 is uncommon. For this promise to be properly realised, ways must be found to limit the vast damage that is now being done by tobacco and to bring home, not only to the many millions of people in developed countries but also the far larger populations elsewhere, the extent to which those who continue to smoke are shortening their expectation of life by so doing.

Jenner Institute

The Jenner Institute is a research institute on the Old Road Campus in Headington, east Oxford, England. It was formed in November 2005 through a partnership between the University of Oxford and the UK Institute for Animal Health. It is associated with the Nuffield Department of Medicine, in the Medical Sciences Division of Oxford University. The institute receives charitable support from the Jenner Vaccine Foundation.The institute is led by Prof. Adrian Hill. The institute develops vaccines and carries out clinical trials for diseases including malaria, tuberculosis (vaccine MVA85A), ebola, and MERS-Coronavirus.In 2020, the institute successfully developed the Oxford–AstraZeneca COVID-19 vaccine, in a project backed by private companies including Oxford Sciences Innovation, Google Ventures, and Sequoia Capital, among others. When developed, the UK government backed trials, purchased 100 million doses, and encouraged Oxford to work with AstraZeneca, a company based in Europe, instead of Merck & Co., a US-based company; while the US gave US$1.2bn of government funding in return for 300 million doses. It collaborated with Italy's Advent Srl (part of the IRBM Group) on the development and Germany's Merck Group on the manufacture of the COVID-19 vaccine. Vaccinologist Dame Sarah Gilbert was one of the leading scientists involved in the development.The institute is named after the English physician and immunization pioneer Edward Jenner (1749–1823), who was a major contributor to the development of the smallpox vaccine.